Fused tricyclic compound having aldose reductase inhibitory activity
AssigneeNational University Corporation University of Toyama
InventorsNaoki TOYOOKA, Atsushi KATO, Isao ADACHI
Life of this patent
Estimating the term…
Loading patent…
AssigneeNational University Corporation University of Toyama
InventorsNaoki TOYOOKA, Atsushi KATO, Isao ADACHI
Estimating the term…
A fused tricyclic compound having aldose reductase inhibitory activity and shown by the following formula, wherein R1 represents 1 to 3 atoms or substituents selected from a hydrogen atom, a halogen atom, a substituted or unsubstituted alkyl, cycloalkyl, alkylene, or alkoxy group, and a protected or unprotected hydroxyl or carboxyl group, R2 represents a protected or unprotected carboxyl group, R3 represents 1 or 2 atoms or substituents selected from a hydrogen atom, a halogen atom, an oxo group, a substituted or unsubstituted alkyl or alkoxy group, and a protected or unprotected carboxyl group, A represents an alkylene group, and B represents an oxygen atom, a sulfur atom, or a group shown by the following formula, wherein R4 represents an alkyl or aryl group substituted by an aryl, cycloalkyl, or heterocyclic group, and X represents an oxygen atom or a sulfur atom, provided that, when B represents a group shown by the following formula: wherein R4 represents an alkyl or aryl group substituted with an aryl, cycloalkyl, or heterocyclic group, X represents a sulfur atom.
A fused tricyclic compound shown by the following formula:
An aldose reductase inhibitor comprising a fused tricyclic compound shown by the following formula:
A therapeutic agent comprising a fused tricyclic compound shown by the following formula as a main ingredient:
Dependencies are inferred from the claim text.